FRIDAY, Nov. 20, 2020 — Less than one in 20 eligible U.S. adults receives annual…
View More Less Than One in 20 Eligible Adults Receives Lung Cancer Screening
Home »
Hormone Therapy for Prostate Cancer May Raise Heart Risks
FRIDAY, Nov. 20, 2020 — Hormone therapy can be a lifesaver for men with prostate…
View More Hormone Therapy for Prostate Cancer May Raise Heart Risks
New drug for metastatic colorectal cancer enters phase 3 trial
A new therapy for metastatic colorectal cancer that has been granted fast-track designation by the…
View More New drug for metastatic colorectal cancer enters phase 3 trial
Biomaterial-based cancer vaccine combines chemo and immunotherapy to treat triple-negative breast cancer
Patients with cancer have multiple treatment options available to them today, but each has its…
View More Biomaterial-based cancer vaccine combines chemo and immunotherapy to treat triple-negative breast cancer
Keke Wyatt and Her Son Rahjah, 18, Reflect on His Cancer Battle
Celebrating her son’s health! Keke Wyatt opened up about her “healed” 18-year-old son Rahjah’s leukemia…
View More Keke Wyatt and Her Son Rahjah, 18, Reflect on His Cancer Battle
New prognostic markers for colon cancer identified
Gut-associated lymphoid tissue represents an integral part of the immune system. Among the powerful players…
View More New prognostic markers for colon cancer identified
Al Roker Reveals Prostate Cancer Diagnosis, Will Undergo Surgery: 'It's a Little Aggressive'
Al Roker revealed Friday that he's been diagnosed with prostate cancer. During the Today show…
View More Al Roker Reveals Prostate Cancer Diagnosis, Will Undergo Surgery: 'It's a Little Aggressive'
Al Roker Has a ‘Bit More Aggressive’ Form of Prostate Cancer — Here’s What to Know
Al Roker and his doctors are sharing more about the Today weatherman and co-host’s prostate…
View More Al Roker Has a ‘Bit More Aggressive’ Form of Prostate Cancer — Here’s What to Know
Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer
In the scientific journal Nature Medicine, researchers in the Netherlands report that neoadjuvant immunotherapy using…
View More Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer
Anticancer compounds for B cell cancer therapy targeting cellular stress response
Researchers at The Wistar Institute and collaborators from the University of Notre Dame are developing…
View More Anticancer compounds for B cell cancer therapy targeting cellular stress response